This Tiny ASX Stock Just Got a White House Nod
...and a 50% opening-day pop
Not investment advice. Disseminated on behalf of Resolution Minerals (ASX: RML | OTCQB: RLMLF).
Most people still think of critical minerals as a slow, boring corner of the market. Lumps of rock. Slide decks. Permitting timelines measured in decades.
But while nobody was watching, Washington quietly turned it into one of the most aggressively funded industrial policies of the decade. Over $350 million has already been directed at domestic antimony projects in the last 18 months. The Department of War can now take direct equity stakes in mining companies. The EXIM Bank is writing billion-dollar checks.
The catch: almost all of that money is flowing to companies that are listed in the U.S., or about to be.
That’s the frame for what happened last week.
What Actually Happened on April 8
On Wednesday, April 8, 2026, Resolution Minerals (ASX: RML) announced it had been granted FAST-41 federal permitting facilitation status for its Antimony Ridge project in Idaho.
The stock opened up more than 50% on the news.
Translation: FAST-41 is a White House–level designation. It’s the U.S. federal government formally flagging a project as nationally significant and putting it on a public dashboard with coordinated permitting timelines. Perpetua Resources — the $3.7B Stibnite project literally next door — spent nearly a decade in the federal permitting system without it. RML just got it before a single drill has turned at Antimony Ridge.
That’s the signal. Now the setup.
The Setup
RML owns 100% of the Horse Heaven project in Valley County, Idaho. One land package, three commodities the U.S. government has classified as strategic:
Antimony. China controls >90% of global supply. It banned exports to the U.S. entirely in December 2024. The partial suspension expires November 2026. RML’s surface grab samples at Antimony Ridge returned up to 49.8% Sb — several multiples of typical Chinese mine grades.
Tungsten. China controls ~80% of global production. APT prices are up roughly 500% in the past 12 months. The DFARS ban on Chinese-origin tungsten in U.S. defense contracts takes effect January 1, 2027. RML owns a ~2,000-tonne tungsten stockpile assaying at 1.85% WO₃ — about ten times the global underground average — plus the processing mill to handle it.
Gold. Phase 1 drilling at Golden Gate returned broad near-surface gold in every single hole, including 253m @ 1.5 g/t Au from surface. A 45-hole, 13,700m Phase 2 program kicks off in May 2026.
Why the NASDAQ Listing Is the Real Catalyst
RML filed its Form F-20 with the SEC in February 2026. The listing is expected in H1 2026.
The reason this matters is a pattern that’s now hard to ignore:
Nova Minerals — NASDAQ listing → $43.4M DPA Title III award for its Alaskan antimony project.
Almonty Industries — NASDAQ listing → US$219M raised across two offerings in six months.
US Antimony — $245M sole-source DLA contract plus $27M in direct DoW investment.
Perpetua (RML’s next-door neighbor) — $2.7B EXIM Bank loan commitment and $80M+ in DoD grants.
Translation: a NASDAQ listing isn’t just a capital markets event for a U.S.-assets miner right now. It’s the door that unlocks government checks.
The Valuation Argument, In Plain English
A third party reportedly offered — and was rejected at — A$225M for Horse Heaven alone in August 2025. That was before the gold discovery, before last week’s FAST-41 designation, and before tungsten prices went up 500%.
At A$0.052, the whole company trades at an enterprise value of roughly A$94M.
That’s the core of it. You don’t need heroic assumptions. You need the offer from last August to still mean something.
Near-Term Catalyst Calendar
This is a dense event sequence, and in our view the market is materially underweighting it at the current price.
Our full initiation report on RML — rating, price target, risk factors, SOTP valuation — is available at research.cashugroup.com.
Disclaimer
We provide only general financial product advice. You should note that general advice does not relate specifically to you and is prepared without taking into account any of your objectives, financial situation or needs. As a result, before acting on the general advice, you should consider the appropriateness of the advice, having regard to your objectives, financial situation and needs.
US Person: This report is intended for distribution in Australia only. It is not directed at persons in the United States and does not constitute an offer to buy or sell securities in the United States.
You should consider seeking the advice of relevant legal, taxation, superannuation, financial and/or other relevant advisors before the information is acted on. The general advice provided relates to securities which are listed on an exchange (usually the Australian Stock Exchange).
You should consider any information published by the listed company (including, without limitation, any prospectus, ASX announcements, or other investor updates published by the relevant company) before acquiring or investing in any shares. Whilst Cashu Research has taken reasonable care, there is no guarantee by either Cashu Research, or its AFSL provider, ASG, that the information in this Research Report is accurate or up to date.
Cashu Research or Cashu Group may receive fees for research or corporate communication services from companies mentioned in this report. Cashu Research, its directors, employees or associates may hold or trade securities in these companies and may change such holdings without notice.
Rating Distribution: Cashu Research rating definitions: BUY (expected return >15% over 12 months); HOLD (-15% to +15%); SELL (<-15%). As at 8 April 2026, Cashu Research rates 85% of covered securities BUY, 0% HOLD, 15% SELL.
The general advice in this Research Report is provided by Cashu Research. Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).
Report prepared by Cashu Research, a division of Cashu Group. This report has been authored and issued by the analyst(s) Fox Slotemaker.